Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hoc analyses of the EPOC trial
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|17 Jul 2014||Submitted||Original manuscript|
|22 Aug 2014||Reviewed||Reviewer Report - Tereza Gabelic|
|23 Aug 2014||Reviewed||Reviewer Report - Tomas Uher|
|6 Oct 2014||Author responded||Author comments - Luigi Barbato|
|Resubmission - Version 2|
|6 Oct 2014||Submitted||Manuscript version 2|
|28 Oct 2014||Author responded||Author comments - Luigi Barbato|
|Resubmission - Version 3|
|28 Oct 2014||Submitted||Manuscript version 3|
|6 Nov 2014||Editorially accepted|
|26 Nov 2014||Article published||10.1186/s12883-014-0220-1|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.